Sarissa Capital Management LP → Alkermes plc. ALKS

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 1 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 5.86

19,013,418 shares short · -7.7% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-06	Gaffin David Joseph	officer	Sale	2,034	$34.57	$70K

Other 13D/G Filings on Alkermes plc.

Filed	Form	Filer	Stake	Shares
2018-01-04	SC	PRIMECAP MANAGEMENT CO/CA/	—	—	view →

Other Filings by Sarissa Capital Management LP

Filed	Form	Issuer	Stake	Shares
2025-03-17	SCHEDULE	Innoviva, Inc. INVA	4.70%	2,966,022	view →
2025-03-07	SCHEDULE	Innoviva, Inc. INVA	8.40%	5,237,161	view →
2018-04-03	SC	EMMAUS LIFE SCIENCES, INC.	—	—	view →
2018-03-23	SC	APRICUS BIOSCIENCES, INC.	—	—	view →
2018-03-19	SC	NOVELION THERAPEUTICS INC.	—	—	view →
2018-01-31	SC	APRICUS BIOSCIENCES, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →